Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
II类HLA-DRB4是转移性非小细胞肺癌免疫治疗后生存的预测性生物标志物。
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-48546-y
Jiang, Cindy Y; Zhao, Lili; Green, Michael D; Ravishankar, Shashidhar; Towlerton, Andrea M H; Scott, Anthony J; Raghavan, Malini; Cusick, Matthew F; Warren, Edus H; Ramnath, Nithya